These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35586707)

  • 1.
    Kwon A; Ibrahim I; Le T; Jaso JM; Weinberg O; Fuda F; Chen W
    Leuk Res Rep; 2022; 17():100323. PubMed ID: 35586707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY; Song IC; Kim J; Kwon GC
    Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A; Gao J; Chen YH; Abaza Y; Altman J; Jennings L; Vormittag-Nocito E; Sukhanova M; Lu X; Chen Q
    Hum Pathol; 2024 Jul; 149():66-74. PubMed ID: 38879086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid Disease with the CSF3R T618I Mutation after CLL.
    Couto ME; Bizarro S; Sousa D; Domingues N; Oliveira I; Martins G; Teixeira MR; Mariz M
    Case Rep Hematol; 2020; 2020():6670965. PubMed ID: 33414971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
    Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
    Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.
    Bezerra ED; Lasho TL; Finke CM; Saliba AN; Elliott MA; Pardanani AD; Gangat N; Mangaonkar AA; Ketterling RP; Tefferi A; Solary E; Patnaik MM
    Blood Cancer J; 2021 Mar; 11(3):54. PubMed ID: 33707412
    [No Abstract]   [Full Text] [Related]  

  • 13. CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis.
    Zhang X; Ghiuzeli C; Jou E; Hsu P; Kolitz J; Brody JP
    Leuk Res Rep; 2022; 17():100334. PubMed ID: 35795468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational landscape of chronic myelomonocytic leukemia in Chinese patients.
    Nie Y; Shao L; Zhang H; He CK; Li H; Zou J; Chen L; Ji H; Tan H; Lin Y; Ru K
    Exp Hematol Oncol; 2022 May; 11(1):32. PubMed ID: 35610628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.
    Cui Y; Tong H; Du X; Li B; Gale RP; Qin T; Liu J; Xu Z; Zhang Y; Huang G; Jin J; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Exp Hematol Oncol; 2015; 4():14. PubMed ID: 26019984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
    Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
    J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related mutations and chronic myelomonocytic leukemia.
    Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
    Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report.
    Pelkey LJ; Graham DM; Zakem MH; Muza-Moons MM
    Cureus; 2022 Feb; 14(2):e22422. PubMed ID: 35228982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I diagnose and treat chronic myelomonocytic leukemia.
    Patnaik MM
    Haematologica; 2022 Jul; 107(7):1503-1517. PubMed ID: 35236051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico.
    Jiang Z; Sun X; Wu Z; Alhatem A; Zheng R; Liu D; Wang Y; Kumar D; Xia C; You B; Wang H; Liu C; Jiang JG
    Oncotarget; 2020 Nov; 11(47):4411-4420. PubMed ID: 33315966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.